triple glp-1/gip/glucagon receptor agonist Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care The Road towards Triple Agonists:
Description
Ozempic is a medication containing semaglutide, a synthetic analog of GLP-1 specifically designed to enhance and extend these beneficial effects
Available: [12] A
doi: 10.1056/NEJMsr1606602 [DOI] [PMC free article] [PubMed] [Google Scholar] 7
In fact, says Dr
Wilding, J
Its role in glucose homeostasis and its application in diabetes treatment
